274 related articles for article (PubMed ID: 34446022)
1. Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India.
Singh K; Kumari R; Gupta S; Tripathi R; Srivastava A; Shakya V; Gupta A; Anupurba S
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):56. PubMed ID: 34446022
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
[TBL] [Abstract][Full Text] [Related]
3. Burden of baseline resistance of Mycobacterium tuberculosis to fluoroquinolones and second-line injectables in central India.
Desikan P; Panwalkar N; Chaudhuri S; Khan Z; Punde RP; Pauranik A; Mirza SB; Ranjan R; Anand S; Sachdeva KS
Trans R Soc Trop Med Hyg; 2020 Apr; 114(4):249-254. PubMed ID: 32003797
[TBL] [Abstract][Full Text] [Related]
4. Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China.
Gao Y; Zhang Z; Deng J; Mansjö M; Ning Z; Li Y; Li X; Hu Y; Hoffner S; Xu B
J Infect; 2018 Oct; 77(4):328-334. PubMed ID: 29969597
[TBL] [Abstract][Full Text] [Related]
5. Robustness of the Line Probe Assay for the Rapid Diagnosis and Characterization of Mutations in Extensively Drug-Resistant Tuberculosis.
Ninan MM; Rupali P; James P; Michael JS
Microb Drug Resist; 2019; 25(6):799-804. PubMed ID: 30785833
[No Abstract] [Full Text] [Related]
6. Correlating clinical breakpoint concentration of moxifloxacin with gyrA mutations using the GenoType MTBDRsl assay Version 2.0.
Sidiq Z; Hanif M; Dwivedi KK; Chopra KK; Khanna A; Vashishat BK
Indian J Tuberc; 2023 Jul; 70(3):361-365. PubMed ID: 37562913
[TBL] [Abstract][Full Text] [Related]
7. Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
Rahman SMM; Nasrin R; Rahman A; Ahmed S; Khatun R; Uddin MKM; Rahman MM; Banu S
PLoS One; 2021; 16(12):e0261329. PubMed ID: 34914803
[TBL] [Abstract][Full Text] [Related]
8. Performance of the MTBDRsl assay in Georgia.
Tukvadze N; Bablishvili N; Apsindzelashvili R; Blumberg HM; Kempker RR
Int J Tuberc Lung Dis; 2014 Feb; 18(2):233-9. PubMed ID: 24429319
[TBL] [Abstract][Full Text] [Related]
9. GenoType
Theron G; Peter J; Richardson M; Warren R; Dheda K; Steingart KR
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD010705. PubMed ID: 27605387
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study.
Tagliani E; Cabibbe AM; Miotto P; Borroni E; Toro JC; Mansjö M; Hoffner S; Hillemann D; Zalutskaya A; Skrahina A; Cirillo DM
J Clin Microbiol; 2015 Sep; 53(9):2961-9. PubMed ID: 26179309
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of MTBDR
Chandak RJ; Malhotra B; Bhargava S; Goel SK; Verma D; Tiwari J
Int J Tuberc Lung Dis; 2019 Dec; 23(12):1257-1262. PubMed ID: 31931908
[No Abstract] [Full Text] [Related]
12. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
13. Performance of the GenoType MTBDRsl assay for the detection second-line anti-tuberculosis drug resistance.
Lee YS; Lee BY; Jo KW; Shim TS
J Infect Chemother; 2017 Dec; 23(12):820-825. PubMed ID: 29066216
[TBL] [Abstract][Full Text] [Related]
14. Genotype MTBDRsl version 2 and phenotypic drug resistance detection of
Radhakrishnan R; Prabuseenivasan S; Hannah S; Vaishanavee V; Senthildevi V; Kannadhasan T; Suchithra R; Rajendran P; Chinnaiyan P; Jayabal L; Frederick A; Shanmugam S
Int J Mycobacteriol; 2023; 12(3):299-304. PubMed ID: 37721236
[TBL] [Abstract][Full Text] [Related]
15. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
Ei PW; Aung WW; Nyunt WW; Swe TL; Htwe MM; Win SM; Aung ST; Chang CL; Lee HY; Lee JS
Int J Tuberc Lung Dis; 2018 Jan; 22(1):47-53. PubMed ID: 29297425
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection of extensively drug-resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an Intermediate Reference Laboratory in India.
Vashistha H; Hanif M; Saini S; Khanna A; Sharma S; Sidiq Z; Ahmed V; Dubey M; Chopra KK; Shrivastava D
Indian J Tuberc; 2016 Jul; 63(3):144-148. PubMed ID: 27865234
[TBL] [Abstract][Full Text] [Related]
17. High degree of fluoroquinolone resistance among pulmonary tuberculosis patients in New Delhi, India.
Sharma R; Sharma SK; Singh BK; Mittal A; Kumar P
Indian J Med Res; 2019 Jan; 149(1):62-66. PubMed ID: 31115377
[TBL] [Abstract][Full Text] [Related]
18. Rapid detection of drug resistance and mutational patterns of extensively drug-resistant strains by a novel GenoType® MTBDRsl assay.
Singh AK; Maurya AK; Kant S; Umrao J; Kushwaha RA; Nag VL; Dhole TN
J Postgrad Med; 2013; 59(3):179-85. PubMed ID: 24029194
[TBL] [Abstract][Full Text] [Related]
19. Non-actionable Results, Accuracy, and Effect of First- and Second-line Line Probe Assays for Diagnosing Drug-Resistant Tuberculosis, Including on Smear-Negative Specimens, in a High-Volume Laboratory.
Pillay S; de Vos M; Derendinger B; Streicher EM; Dolby T; Scott LA; Steinhobel AD; Warren RM; Theron G
Clin Infect Dis; 2023 Feb; 76(3):e920-e929. PubMed ID: 35788278
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the GenoType MTBDR
Gardee Y; Dreyer AW; Koornhof HJ; Omar SV; da Silva P; Bhyat Z; Ismail NA
J Clin Microbiol; 2017 Mar; 55(3):791-800. PubMed ID: 27974543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
